Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tack Optimized Balloon Angioplasty Post-Market Study

NCT05361967 is registered in ClinicalTrials.gov with Spectranetics Corporation as lead sponsor.

NCT NCT05361967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05361967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tack Optimized Balloon Angioplasty Post-Market Study
Lead sponsor
Spectranetics Corporation
Phase
Observational
Overall status
Terminated
Start date
March 30, 2023
Completion date
June 1, 2024
Enrollment
6 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

arterial dissection, dissection, pad, pad - peripheral arterial disease, peripheral arterial disease, peripheral vascular diseases